CHDR Annual Report 2024
Contents 2024
  • Homepage
  • 2024 in perspective
  • Developing drugs
  • Developing methods
  • Developing people
  • 2024 stories
Other years

Developing drugs

CHDR’s research groups made vital contributions to the development of new drugs in 2024. In this we are proud to collaborate with a range of valued clients and partners, some of whom also share their stories below.

Using TMS and EEG to study a novel class of drug

Towards a novel class of painkillers

A new focus on the central cholinergic system

Clinical study explores the effects of cannabis on chronic pain

Pharmacological surprises with a well-known psychedelic compound

‘It was all smooth sailing’ — Dr Mads Kjolby, Vesper Bio

Successful recruitment of patients with celiac disease

Resetting the immune system in SLE and RA

Studying novel immunomodulatory agents

CHDR

‘A brilliant example of an early proof of mechanism’ — Dr Joachim Tillner, Sanofi

Back to homepage
  • © CHDR 2026
  • +31 (0)71 5246400
  • info@chdr.nl
  • www.chdr.nl